PUBLICATIONS

for the most up-to-date list on PubMed, click here

Research Articles

  1. Shearer, K. E., Rickert, E. L., Peterson, A. C., & Weatherman, R. V. “Dissecting rapid estrogen signaling with conjugates.” Steroids. 2012, 77, 968-973.(link)
  2. Shah, V. P.; Chegini, H. A.; Vishneski, S. R.; Weatherman, R. V.; Blackmore, P. F.; Dobrydneva, Y. Tamoxifen promotes superoxide production in platelets by activation of PI3-Kinase and NADPH oxidase pathways. Thromb. Res. 2012, 129, 36–42. (link)
  3. Rickert, EL, Oriana S, Hartman-Frey C, Long X, Webb TT, Nephew KP, Weatherman RV. Synthesis and Characterization of Fluorescent 4-Hydroxytamoxifen Conjugates with Unique Antiestrogenic Properties. Bioconj. Chem. 2010; 21, 903-10. (link)
  4. Rickert, EL. Trebley, JP, Peterson, AC, Morrell, MM, Weatherman, RV. Synthesis and Characterization of Bioactive Tamoxifen-conjugated Polymers. Biomacromol. 2007; 8(11): 3608-3612. (link).
  5. Dobrydneva, Y, Weatherman, RV, Trebley, JP,  Morrell, MM, Fitzgerald, MC, Fichandler, CE, Chatterjie, N, Blackmore, P. Tamoxifen stimulates calcium entry into human platelets. J Cardiovasc Pharmacol. 2007; 50(4):380-390. (link).
  6. Fan, M, Rickert, EL, Chen, L, Aftab, SA, Nephew, KP and Weatherman, RV. Characterization of molecular and structural determinants of selective estrogen receptor downregulators. Breast Cancer Res Treat. 2007; 103(1):37-44.(link)
  7. Johnson, MD, Zuo, H, Lee, KH, Trebley, JP, Rae, JM, Weatherman, RV, Desta, Z, Flockhart, DA and Skaar, TC. Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen. Breast Cancer Res Treat. 2004; 85(2):151-9. (link)

Conference Proceedings

  1. Trebley, JP, Rickert, EL, Reyes, PT and Weatherman, RV. Tamoxifen-based probes for the study of estrogen receptor-mediated transcription. Ernst Schering Res Found Workshop. 2006, 58: 75-87. (link)

Reviews & Commentaries

  1. Weatherman RV: The role of selective estrogen receptor destabilizers (SERDs) in breast cancer therapy. Drugs of the Future. 2016, 41, 361. (link)
  2. Weatherman, R. V. Review of “Cancer Drug Discovery and Development-Hormone Therapy in Breast and Prostate Cancer. Edited by V. Craig Jordan and Barrington JA Furr.” ChemMedChem 2010, 5, 1152 – 1154. (link)
  3. Weatherman, R. V., “Untangling the Estrogen Receptor Web: Tools to Selectively Study Estrogen binding Receptors”. in Nuclear Receptors as Drug Targets. 2008Ottow, E.; Weinmann, H., Eds. Wiley-VCH: Weinhem, 47-64. (link)
  4. Weatherman, RV, “Hormone Signaling” in Wiley Encyclopedia of Chemical Biology, 2008, Begley, TP, ed. John Wiley & Sons, Inc. DOI: 10.1002/9780470048672 (link)
  5. Weatherman. Sensing estrogen’s many pathways. ACS Chem Biol. 2008; 3(6): 338-40 (link)
  6. Weatherman, RV. A triple play for thyroid hormone. ACS Chem Biol. 2007; 2(6):377-9.(link)
  7. Weatherman, RV. Untangling the estrogen receptor web. Nat Chem Biol. 2006; 2(4):175-6.(link)
  8. Weatherman, RV. Chemical approaches to studying transcription. Org Biomol Chem. 2003; 1: 3257-60.(link)